Showing results (911-920 of 1,447) with videos related to
Sort By:
Pageof 145
Proteomics. Clinical Applications|December 8, 2010
Characterizations and validations of novel antibodies toward translational researchReginald Williams, Joon-Yong Chung, Kris Ylaya, et al.Proteomics. Clinical Applications|February 1, 2011
CE-MS in biomarker discovery, validation, and clinical applicationHarald Mischak, Joost P SchanstraProteomics. Clinical Applications|February 1, 2011
Proteomic analysis of multiple myeloma: current status and future perspectivesFeng Ge, Li-Jun Bi, Sheng-Ce Tao, et al.Proteomics. Clinical Applications|February 1, 2011
Lectin-affinity chromatography brain glycoproteomics and Alzheimer disease: insights into protein alterations consistent with the pathology and progression of this dementing disorderD Allan Butterfield, Joshua B OwenProteomics. Clinical Applications|March 2, 2011
Effect of fenofibrate treatment on the low molecular weight urinary proteome of healthy volunteersChristelle Foucher, Eric Schiffer, Harald Mischak, et al.Proteomics. Clinical Applications|December 25, 2010
Report from the Wellcome Trust/EBA “Perspectives in Clinical Proteomics” retreat--a strategy to implement next-generation proteomic analyses to the clinic for patient benefit: pathway to translationScott D Patterson, Jennifer E Van Eyk, Rosamonde E BanksProteomics. Clinical Applications|December 25, 2010
Hemoglobin depletion from plasma: considerations for proteomic discovery in sickle cell disease and other hemolytic processesLisa M Williams, Zongming Fu, Pratima Dulloor, et al.Proteomics. Clinical Applications|June 19, 2010
Proteomics cataloging analysis of human expressed prostatic secretions reveals rich source of biomarker candidatesRunsheng Li, Yan Guo, Bang Ming Han, et al.Proteomics. Clinical Applications|June 19, 2010
Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancerBiaoyang Lin, James T White, Jian Wu, et al.Proteomics. Clinical Applications|January 21, 2012
Surveying proteolytic processes in human cancer microenvironments by microdialysis and activity-based mass spectrometryMarkus Hardt, David K Lam, John C Dolan, et al.Pageof 145